Neurocrine Biosciences (NBIX) – FDA News
-
Neurocrine Biosciences (NBIX) Reports Positive Phase 2 Data for NBI-1065845
-
Neurocrine Biosciences (NBIX) and Sentia Medical Sciences Extend Research Collaboration to Discover Novel CRF Peptides
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to NBIX Stock Lookup